These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 8248653)

  • 1. A case for Bayesianism in clinical trials.
    Berry DA
    Stat Med; 1993 Aug; 12(15-16):1377-93; discussion 1395-404. PubMed ID: 8248653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introduction to Bayesian methods III: use and interpretation of Bayesian tools in design and analysis.
    Berry DA
    Clin Trials; 2005; 2(4):295-300; discussion 301-4, 364-78. PubMed ID: 16281428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethics and statistical methodology in clinical trials.
    Palmer CR
    J Med Ethics; 1993 Dec; 19(4):219-22. PubMed ID: 8308877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moving in Parallel Toward a Modern Modeling Epistemology: Bayes Factors and Frequentist Modeling Methods.
    Rodgers JL
    Multivariate Behav Res; 2016; 51(1):30-4. PubMed ID: 26881955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
    Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
    J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Bayesian approach to stochastic cost-effectiveness analysis.
    Briggs AH
    Health Econ; 1999 May; 8(3):257-61. PubMed ID: 10348420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian designs and the control of frequentist characteristics: a practical solution.
    Ventz S; Trippa L
    Biometrics; 2015 Mar; 71(1):218-226. PubMed ID: 25196832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Bayesian New Statistics: Hypothesis testing, estimation, meta-analysis, and power analysis from a Bayesian perspective.
    Kruschke JK; Liddell TM
    Psychon Bull Rev; 2018 Feb; 25(1):178-206. PubMed ID: 28176294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Bayesian-frequentist two-stage single-arm phase II clinical trial design.
    Dong G; Shih WJ; Moore D; Quan H; Marcella S
    Stat Med; 2012 Aug; 31(19):2055-67. PubMed ID: 22415966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous safety monitoring for randomized controlled clinical trials with blinded treatment information. Part 2: Statistical considerations.
    Ball G; Piller LB
    Contemp Clin Trials; 2011 Sep; 32 Suppl 1():S5-7. PubMed ID: 21664986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian randomized clinical trials: From fixed to adaptive design.
    Yin G; Lam CK; Shi H
    Contemp Clin Trials; 2017 Aug; 59():77-86. PubMed ID: 28455232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian approach to noninferiority trials for proportions.
    Gamalo MA; Wu R; Tiwari RC
    J Biopharm Stat; 2011 Sep; 21(5):902-19. PubMed ID: 21830922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian methods for the design and analysis of noninferiority trials.
    Gamalo-Siebers M; Gao A; Lakshminarayanan M; Liu G; Natanegara F; Railkar R; Schmidli H; Song G
    J Biopharm Stat; 2016; 26(5):823-41. PubMed ID: 26247350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of Bayesian and frequentist methods in random-effects network meta-analysis of binary data.
    Seide SE; Jensen K; Kieser M
    Res Synth Methods; 2020 May; 11(3):363-378. PubMed ID: 31955519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robust meta-analytic-predictive priors in clinical trials with historical control information.
    Schmidli H; Gsteiger S; Roychoudhury S; O'Hagan A; Spiegelhalter D; Neuenschwander B
    Biometrics; 2014 Dec; 70(4):1023-32. PubMed ID: 25355546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applying Bayesian ideas in drug development and clinical trials.
    Spiegelhalter DJ; Freedman LS; Parmar MK
    Stat Med; 1993 Aug; 12(15-16):1501-11; discussion 1513-7. PubMed ID: 8248659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian predictive approach to interim monitoring in clinical trials.
    Dmitrienko A; Wang MD
    Stat Med; 2006 Jul; 25(13):2178-95. PubMed ID: 16007570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis in the design and monitoring of clinical trials.
    DerSimonian R
    Stat Med; 1996 Jun; 15(12):1237-48; discussion 1249-52. PubMed ID: 8817798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian predictive probabilities: a good way to monitor clinical trials.
    Ferreira D; Ludes PO; Diemunsch P; Noll E; Torp KD; Meyer N
    Br J Anaesth; 2021 Feb; 126(2):550-555. PubMed ID: 33129491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.